Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free Medtronic Infuse bone graft cases. Here at Leading Justice, we can custom-tailor your firm’s Medtronic advertising needs and help you sign up cases via internal cash buys. Our clients simply pay an agency fee to cover the cost of Medtronic Infuse advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. In addition, we cross-qualify all of our contacts, meaning any data we generate that doesn’t qualify for the target campaign is reviewed to determine whether it’s eligible for another type of claim. By utilizing advanced approaches to target contacts specifically related to Medtronic Infuse bone grafts and side effects like nerve damage, difficulty breathing and swallowing, and death, Leading Justice will increase your firm’s Medtronic Infuse case load. If you are interested in helping victims of alleged Medtronic bone graft side effects, our vast consumer reach and direct advertising strategies at Leading Justice give you the competitive edge and confidence to allocate your full budget and rest easy knowing your money is being used in the best way possible.
Each law firm we work with at Leading Justice has a direct impact on how we classify claims as qualified or not. While our experience working with plaintiff law firms allows us to recognize a great case when we see one, we will customize our Medtronic Infuse case intake specifications to the exact criteria you are seeking. So, if your firm has certain Medtronic bone graft qualifying case criteria you would like us to use, we will train our intake specialists to add this specific criteria to each email and phone call they receive. By eliminating the middle man, Leading Justice offers clients an opportunity for internal cash buys of Medtronic data with zero chance of fraud.
Our Take on the Medtronic Infuse Bone Graft
The Infuse bone graft product was introduced in 2007 by Medtronic – the largest manufacturer of spinal treatments in the world. In the following years, doctors used Infuse for a variety of conditions, including those yet to be approved by federal regulators, assuming that it carried few side effects. In 2008, however, the FDA issued a warning notifying consumers that Medtronic’s infuse product may cause serious side effects when used in off-label cervical spine procedures. At that time, the FDA had received dozens of reports of complications associated with off-label Medtronic Infuse procedures, mainly swelling of throat and neck tissue, resulting in difficulty speaking, swallowing and breathing. Several affected patients required emergency medical treatment, including feeding tubes, tracheotomies and additional surgeries, and some complications have resulted in patient death. As a result of these life-threatening side effect risks, as many as 300 Infuse bone graft lawsuits have already been filed against Medtronic, with close to 1,000 more cases being investigated by product liability attorneys throughout the country.